GlassScriptPhysician profile
William Reeves Johnson
NPI 1154365583
$2,859.49
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $690 · 2021: $761 · 2022: $955.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $569.92 | 2019-2022 | |
| Novo Nordisk INC | $506.39 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.18 | 2019-2022 | |
| Glaxosmithkline, LLC. | $186.55 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $155.33 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $145.71 | 2019-2022 | |
| Abbott Laboratories | $121.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.55 | 2021-2022 | |
| Pfizer INC. | $115.49 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $113.41 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $112.24 | 2021-2022 | |
| Lilly USA, LLC | $92.26 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $64.62 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $62.26 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $51.03 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $41.55 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.08 | 2021-2022 | |
| Daiichi Sankyo INC. | $26.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.62 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $23.36 | 2020-2021 | |
| Ethicon US, LLC | $20.42 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $17.42 | 2021 | |
| Gilead Sciences, INC. | $14.94 | 2020 | |
| Astellas Pharma US INC | $14.20 | 2021 | |
| Welch Allyn | $12.78 | 2020 | |
| Alexion Pharmaceuticals, INC. | $12.30 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.